Andrew Kenneth William Powell is of Aclaris Therapeutics, Inc.. Currently has a direct ownership of 33,523 shares of ACRS, which is worth approximately $133,756. The most recent transaction as insider was on Jun 01, 2024, when has been sold 4,660 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.5K
0% 3M change
133.4% 12M change
Total Value Held $133,756

Andrew Kenneth William Powell Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 01 2024
BUY
Exercise of conversion of derivative security
-
4,660 Added 12.2%
33,523 Common Stock
Mar 04 2024
BUY
Open market or private purchase
$7,500 $1.25 p/Share
6,000 Added 17.21%
28,863 Common Stock
Mar 01 2024
BUY
Open market or private purchase
$10,455 $1.23 p/Share
8,500 Added 27.1%
22,863 Common Stock
Jun 02 2023
BUY
Exercise of conversion of derivative security
-
4,507 Added 23.88%
14,363 Common Stock
Nov 08 2022
SELL
Bona fide gift
-
4,000 Reduced 28.87%
9,856 Common Stock
Jun 03 2022
BUY
Exercise of conversion of derivative security
-
3,356 Added 19.5%
13,856 Common Stock
May 16 2022
SELL
Bona fide gift
-
709 Reduced 6.33%
10,500 Common Stock
Nov 23 2021
SELL
Bona fide gift
-
5,500 Reduced 32.92%
11,209 Common Stock

Also insider at

LNDC
LANDEC CORP \CA\ Healthcare
SBTX
Silverback Therapeutics, Inc. Healthcare
AKW

Andrew Kenneth William Powell

Wayne, PA

Track Institutional and Insider Activities on ACRS

Follow Aclaris Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACRS shares.

Notify only if

Insider Trading

Get notified when an Aclaris Therapeutics, Inc. insider buys or sells ACRS shares.

Notify only if

News

Receive news related to Aclaris Therapeutics, Inc.

Track Activities on ACRS